The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.

The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017 02; 24(1):112-118.

View in: PubMed

subject areas

Age Distribution
Cardio-Renal Syndrome
Chicago
Comorbidity
Coronary Artery Disease
Death, Sudden, Cardiac
Exercise Test
Female
Humans
Incidence
Kidney Failure, Chronic
Male
Middle Aged
Myocardial Perfusion Imaging
Prognosis
Purines
Pyrazoles
Reproducibility of Results
Risk Assessment
Sensitivity and Specificity
Sex Distribution
Single-Blind Method
Survival Rate
Tomography, Emission-Computed, Single-Photon
Vasodilator Agents

authors with profiles

Rami Doukky